Mathieu Guerriaud

Publication Activity (10 Years)

Years Active: 2023-2024
Publications (10 Years): 7

Top Topics

Health Insurance

Toxoplasma Gondii

Top Venues

European journal of health law

Pharmaceutical medicine

This page only lists publications with an associated author ORCID identifier.

Publications

Mathieu Guerriaud, Valérie Siranyan
The Proposal for a Directive on Defective Products: A Game Changer for Innovative Medicinal Products. European journal of health law 31 (1) (2024)
Mathieu Guerriaud, Cyril Poupet, Zineb Lakhrif, Evelyne Kohli, Nathalie Moiré
Are genetically modified protozoa eligible for ATMP status? Concerning the legal categorization of an oncolytic protozoan drug candidate. Gene therapy (2024)
Mathieu Guerriaud, Valérie Siranyan
The Proposal for a Directive on Defective Products: A Game Changer for Innovative Medicinal Products. European journal of health law 31 (1) (2024)
Mathieu Guerriaud, Cyril Poupet, Zineb Lakhrif, Evelyne Kohli, Nathalie Moiré
Are genetically modified protozoa eligible for ATMP status? Concerning the legal categorization of an oncolytic protozoan drug candidate. Gene therapy 31 (5-6) (2024)
Mathieu Guerriaud, Cyril Poupet, Zineb Lakhrif, Evelyne Kohli, Nathalie Moiré
Are genetically modified protozoa eligible for ATMP status? Concerning the legal categorization of an oncolytic protozoan drug candidate. Gene therapy 31 (5-6) (2024)
Mathieu Guerriaud, Valérie Siranyan
The Proposal for a Directive on Defective Products: A Game Changer for Innovative Medicinal Products. European journal of health law (2024)
Mathieu Guerriaud
"Regulatory Sandboxes" Could Solve the Regulatory Problems Encountered in Europe and Arising from Innovation in Biological Medicinal Products. Pharmaceutical medicine (2023)